Literature DB >> 6418507

Optimum Management of juvenile chronic polyarthritis.

J J Calabro.   

Abstract

The early diagnosis of juvenile chronic polyarthritis rests on the recognition of 3 district modes of onset that are important in preventing deformities, blindness, and even death. Systemic onset is characterised by typical systemic features, including high spiking fever and rheumatoid rash; polyarticular onset is characterised by arthritis of more than 4 joints; and pauciarticular onset by involvement of 4 joints or less, most often a knee initially. Management must be individualised, including the use of non-steroidal anti-inflammatory drugs of which aspirin remains the drug of choice. The course of progressive polyarthritis, found in 15% of children, necessitates the additional use of slow-acting agents, such as intramuscular gold. Supportive measures include rest, splinting and exercise. Regular slit-lamp examination is mandatory to screen for asymptomatic iridocyclitis, which if undetected and untreated may result in blindness.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418507     DOI: 10.2165/00003495-198326060-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  18 in total

1.  Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.

Authors:  A L Laaksonen; V Koskiahde; K Juva
Journal:  Scand J Rheumatol       Date:  1974       Impact factor: 3.641

Review 2.  Juvenile rheumatoid arthritis: a review.

Authors:  J Schaller; R J Wedgwood
Journal:  Pediatrics       Date:  1972-12       Impact factor: 7.124

3.  Chronic iridocyclitis in juvenile rheumatoid arthritis.

Authors:  J J Calabro; G R Parrino; P D Atchoo; J M Marchesano; L S Goldberg
Journal:  Arthritis Rheum       Date:  1970 Jul-Aug

4.  Juvenile rheumatoid arthritis persisting inot adulthood.

Authors:  R Jeremy; J Schaller; R Arkless; R J Wedgwood; L A Healey
Journal:  Am J Med       Date:  1968-09       Impact factor: 4.965

5.  Management of juvenile rheumatoid arthritis.

Authors:  J J Calabro
Journal:  Compr Ther       Date:  1981-02

6.  Fever associated with juvenile rheumatoid arthritis.

Authors:  J J Calabro; J M Marchesano
Journal:  N Engl J Med       Date:  1967-01-05       Impact factor: 91.245

7.  Aspirin and fenoprofen (Nalfon) in the treatment of juvenile rheumatoid arthritis results of the double blind-trial. A segment II study.

Authors:  E J Brewer; E H Giannini; J Baum; B Bernstein; C W Fink; H M Emery; J G Schaller
Journal:  J Rheumatol       Date:  1982 Jan-Feb       Impact factor: 4.666

8.  Juvenile rheumatoid arthritis. Mode of onset as key to early diagnosis and management.

Authors:  J J Calabro
Journal:  Postgrad Med       Date:  1981-09       Impact factor: 3.840

9.  Myocarditis in juvenile rheumatoid arthritis.

Authors:  J J Miller; J W French
Journal:  Am J Dis Child       Date:  1977-02

10.  Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis.

Authors:  J E Levinson; J Baum; E Brewer; C Fink; V Hanson; J Schaller
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.